Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
9.77
-0.05 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
9.96
+0.19 (1.94%)
After-hours: Dec 5, 2025, 7:14 PM EST
Design Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -67.45 | -49.59 | -66.86 | -63.31 | -35.53 | -8.28 | |
| Depreciation & Amortization | 0.62 | 0.6 | 0.54 | 0.41 | 0.13 | 0.01 | |
| Loss (Gain) From Sale of Investments | -4.18 | -6.2 | -6.08 | -1.4 | -0.08 | -0.07 | |
| Stock-Based Compensation | 14.59 | 13.07 | 13.09 | 10.93 | 4.69 | 0.45 | |
| Other Operating Activities | 0.41 | 0.01 | 0.03 | 0.06 | 0.02 | 0.04 | |
| Change in Accounts Payable | 3.65 | -1.22 | -1.25 | 5.39 | 2.41 | -0.41 | |
| Change in Unearned Revenue | - | - | - | - | - | -0.2 | |
| Change in Other Net Operating Assets | 0.11 | 0.23 | 1.97 | -3.39 | -1.02 | -0.2 | |
| Operating Cash Flow | -52.25 | -43.11 | -58.56 | -51.32 | -29.38 | -8.67 | |
| Capital Expenditures | -0.16 | -0.34 | -0.26 | -0.92 | -1.54 | -0.08 | |
| Sale of Property, Plant & Equipment | - | - | - | 0.04 | - | - | |
| Investment in Securities | 36.49 | 44.3 | 52.79 | -220.11 | -52.11 | -33.49 | |
| Investing Cash Flow | 36.33 | 43.96 | 52.54 | -220.99 | -53.64 | -33.56 | |
| Short-Term Debt Issued | - | - | - | - | - | 0.2 | |
| Total Debt Issued | - | - | - | - | - | 0.2 | |
| Short-Term Debt Repaid | - | - | - | - | - | -0.4 | |
| Total Debt Repaid | - | - | - | - | - | -0.4 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.2 | |
| Issuance of Common Stock | 0.68 | 0.51 | 0.72 | 0.66 | 254.5 | 0 | |
| Other Financing Activities | - | - | - | -0.43 | - | - | |
| Financing Cash Flow | 0.68 | 0.51 | 0.72 | 0.24 | 379.21 | 44.53 | |
| Net Cash Flow | -15.24 | 1.36 | -5.3 | -272.07 | 296.19 | 2.3 | |
| Free Cash Flow | -52.41 | -43.45 | -58.82 | -52.24 | -30.92 | -8.75 | |
| Free Cash Flow Margin | - | - | - | - | - | -3869.47% | |
| Free Cash Flow Per Share | -0.92 | -0.77 | -1.05 | -0.94 | -0.67 | -0.55 | |
| Cash Interest Paid | - | - | - | - | - | 0.02 | |
| Levered Free Cash Flow | -29.69 | -26.68 | -34.78 | -29.85 | -17.88 | -5.66 | |
| Unlevered Free Cash Flow | -29.69 | -26.68 | -34.78 | -29.85 | -17.88 | -5.66 | |
| Change in Working Capital | 3.76 | -0.99 | 0.73 | 1.99 | 1.4 | -0.81 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.